Cardiovascular Safety Research: Bupivacaine With Vasoconstrictor Versus Ropivacaine in Brachial Plexus Block

• Status: Unknown status
• Trial end date: 2009-07-01
• Target enrollment: 0
• Participant gender: All

Summary

The purpose of this study is to determine if bupivacaine (75% levobupivacaine plus 25% racemic bupivacaine) with vasoconstrictor is effective and safety as ropivacaine in brachial plexus block for orthopedic surgery.

• Phase: Phase 4
• Accepts Healthy Volunteers?: Accepts Healthy Volunteers

Details

• Lead Sponsor: University of Sao Paulo
• Collaborator: Cristália Produtos Químicos Farmacêuticos Ltda.
• Treatments: Bupivacaine; Ropivacaine

Criteria

Inclusion Criteria:

• Patients involved: 48; ASA I and II;

• Surgery: elective upper extremity orthopedic surgery.

Exclusion Criteria:

• Contraindications to anesthesia technique and/or to local anesthetic;

• Participation in different trials in the last two months;

• Antiretroviral users;

• Obesity.